News

Business Insider4y
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia - Markets Insider
NORTH CHICAGO, Ill., Feb. 25, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ...
Business Insider3y
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and ... - Markets Insider
- Seven abstract presentations showcase ongoing research in presbyopia and glaucoma NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it ...
Nasdaq3y
Allergan, an AbbVie Company, to Present Data from its Leading Portfolio of Eye Care Treatments at the 2022 American Glaucoma Society (AGS) Annual Meeting - Nasdaq
--Allergan, an AbbVie company, today announced new data to be presented from Allergan's leading portfolio of eye care treatments at the 2022 American Glaucoma Society Annual Meeting being held in ...
CNN5y
Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol - CNN
Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol. PR Newswire. NORTH CHICAGO, Ill., June 26, 2020.
FOX59 News3y
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
NORTH CHICAGO, Ill., April 19, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data from its leading eye care portfolio at the 2022 American ...
Nasdaq4y
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia - Nasdaq
--Allergan, an AbbVie company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 ophthalmic solution for the ...
WGNO3y
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO ... - WGNO
NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25%, the ...
FOX8 Cleveland3y
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS ... - Fox 8 Cleveland WJW
NORTH CHICAGO, Ill., April 19, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data from its leading eye care portfolio at the 2022 American ...
WHNT3y
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO ...
NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25%, the ...
WGNO3y
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - WGNO
NORTH CHICAGO, Ill., April 19, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data from its leading eye care portfolio at the 2022 American ...
WOOD-TV3y
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology ... - WOODTV.com
NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25%, the ...
FOX8 Cleveland3y
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and ... - Fox 8 Cleveland WJW
NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25%, the ...